RSS-Feed abonnieren
DOI: 10.1055/s-2003-41353
Adipocytokines in Anorexia Nervosa: a Review Focusing on Leptin and Adiponectin
Publikationsverlauf
Received 17 December 2002
Accepted after Revision 11 March 2003
Publikationsdatum:
15. August 2003 (online)
![](https://www.thieme-connect.de/media/hmr/200306/lookinside/thumbnails/10.1055-s-2003-41353-1.jpg)
Abstract
Adipose tissue secretes a large number of physiologically active peptides that often share structural properties with cytokines, and are therefore collectively referred to as ”adipocytokines”. Some of these are almost exclusively secreted by adipose tissue. Leptin, adiponectin and resistin are specific fat-derived hormones that affect fuel homeostasis and insulin action, and may also be involved in hematopoiesis and immune functions. Anorexia nervosa is characterized by chronic self-starvation and severe weight loss, mainly at the expense of adipose tissue. Starvation-induced depletion of fat stores is accompanied by alterations of circulating adipocytokines. Plasma leptin and likely resistin levels are decreased in anorectic patients, while plasma adiponectin levels are increased. These alterations may have potential repercussions in the pathophysiology of anorexia nervosa. Thus, low leptin and high adiponectin may separately or in concert contribute to altered hematopoiesis and immunity, enhanced insulin sensitivity, neuroendocrine disturbances or osteopenia in anorexia nervosa.
Key words
Leptin - Resistin - Adiponectin - Starvation - Insulin Action - Fuel Homeostasis
References
- 1 Lambert M, Lion L, Vanderdonckt J, Maiter D. Anormalies endocriniennes de l'anorexie mentale. Rev Franç Endocrinol Clin. 1997; 38 569-577
- 2 Stoving R K, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res. 1999; 33 139-152
-
3 Rubin R T, Kaye W H.
Anorexia nervosa and others eating disorders. In: Endocrinology. DeGroot LJ and Jameson JL (Eds) Philadelphia; W. B. Saunders Company 2001: 631-641 - 4 Lambert M, Hubert C, Depresseux G, Vande B B, Thissen J P, Nagant d D. Hematological changes in anorexia nervosa are correlated with total body fat mass depletion. Int J Eat Disord. 1997; 21 329-334
- 5 Devuyst O, Lambert M, Rodhain J, Lefebvre C, Coche E. Haematological changes and infectious complications in anorexia nervosa: a case-control study. Q J Med. 1993; 86 791-799
- 6 Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002; 87 2883-2891
- 7 Trayhurn P, Beattie J H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001; 60 329-339
- 8 Ravussin E, Smith S R. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2002; 967 363-378
- 9 Caro J F, Sinha M K, Kolaczynski J W, Zhang P L, Considine R V. Leptin: the tale of an obesity gene. Diabetes. 1996; 45 1455-1462
- 10 Chan J L, Bluher S, Yiannakouris N, Suchard M A, Kratzsch J, Mantzoros C S. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes. 2002; 51 2105-2112
- 11 Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996; 81 3861-3863
- 12 Mantzoros C, Flier J S, Lesem M D, Brewerton T D, Jimerson D C. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab. 1997; 82 1845-1851
- 13 Ferron F, Considine R V, Peino R, Lado I G, Dieguez C, Casanueva F F. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease. Clin Endocrinol. 1997; 46 289-293
- 14 Balligand J L, Brichard S M, Brichard V, Desager J P, Lambert M. Hypoleptinemia in patients with anorexia nervosa: loss of circadian rhythm and unresponsiveness to short-term refeeding. Eur J Endocrinol. 1998; 138 415-420
- 15 Kratzsh J, Lammert A, Bottner A, Seidel B, Mueller G, Thiery J, Hedebrand J, Kiess W. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. J Clin Endocrinol Metab. 2002; 87 4587-4594
- 16 Stoving R K, Vinten J, Handberg A, Ebbesen E N, Hangaard J, Hansen-Nord M, Kristiansen J, Hagen C. Diurnal variation of the serum leptin concentration in patients with anorexia nervosa. Clin Endocrinol. 1998; 48 761-768
- 17 Laughlin G A, Yen S S. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrrhea. J Clin Endocrinol Metab. 1997; 82 318-321
- 18 Casanueva F F, Dieguez C, Popovic V, Peino R, Considine R V, Caro J F. Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery. Biochem Mol Med. 1997; 60 116-120
- 19 Hebebrand J, Blum W F, Barth N, Coners H, Englaro P, Juul A, Ziegler A, Warnke A, Rascher W, Remschmidt H. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry. 1997; 2 330-334
- 20 Ahima R S, Flier J S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000; 11 327-332
- 21 Farooqi I S. Leptin and the onset of puberty: insights from rodent and human genetics. Semin Reprod Med. 2002; 20 139-144
- 22 Ahima R S, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier J S. Role of leptin in the neuroendocrine response to fasting. Nature. 1996; 382 250-252
- 23 Bennett B D, Solar G P, Yuan J Q, Mathias J, Thomas G R, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol. 1996; 6 1170-1180
- 24 Faggioni R, Feingold K R, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001; 15 2565-2571
- 25 Faggioni R, Moser A, Feingold K R, Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol. 2000; 156 1781-1787
- 26 Vande B erg, Malghem J, Devuyst O, Maldague B E, Lambert M J. Anorexia nervosa: correlation between MR appearance of bone marrow and severity of disease. Radiology. 1994; 193 859-864
- 27 Vaisman N, Barak Y, Hahn T, Karov Y, Malach L, Barak V. Defective in vitro granulopoiesis in patients with anorexia nervosa. Pediatr Res. 1996; 40 108-111
- 28 Nova E, Gomez-Martinez S, Morande G, Marcos A. Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa. Br J Nutr. 2002; 88 183-188
- 29 Reseland J, Gordeladze J. Role of leptin in bone growth: central player or peripheral supporter?. FEBS Lett. 2002; 528 540
- 30 Goldstone A P, Howard J K, Lord G M, Ghatei M A, Gardiner J V, Wang Z L, Wang R M, Girgis S I, Bailey C J, Bloom S R. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun. 2002; 295 475-481
- 31 Berg A H, Combs T P, Scherer P E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002; 13 84-89
- 32 Tsao T S, Lodish H F, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol. 2002; 440 213-221
- 33 Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res. 2002; 34 469-474
- 34 Fruebis J, Tsao T S, Javorschi S, Ebbets-Reed D, Erickson M R, Yen F T, Bihain B E, Lodish H F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001; 98 2005-2010
- 35 Berg A H, Combs T P, Du X, Brownlee M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001; 7 947-953
- 36 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001; 7 941-946
- 37 Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn B B, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8 1288-1295
- 38 Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100 2473-2476
- 39 Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002; 277 25 863-25 866
- 40 Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner A J, Tomiyama Y, Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages. Blood. 2000; 96 1723-1732
- 41 Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257 79-83
- 42 Haque W A, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002; 87 2395
- 43 Delporte M L, Brichard S M, Hermans M P, Beguin C, Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf). 2003; 58 22-29
- 44 Yang W S, Lee W J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C L, Chen C L, Tai T Y, Chuang L M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001; 86 3815-3819
- 45 Halleux C M, Takahashi M, Delporte M L, Detry R, Funahashi T, Matsuzawa Y, Brichard S M. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun. 2001; 288 1102-1107
- 46 Zuniga-Guajardo S, Garfinkel P E, Zinman B. Changes in insulin sensitivity and clearance in anorexia nervosa. Metabolism. 1986; 35 1096-1100
- 47 Fukushima M, Nakai Y, Taniguchi A, Imura H, Nagata I, Tokuyama K. Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis. Metabolism. 1993; 42 1164-1168
- 48 Hermans M P, Lambert M J. HOMA-modelling of insulin sensitivity and beta-cell function in anorexia nervosa. European Eating Disorders Review. 2002; 10 41-50
- 49 Bogan J S, Lodish H F. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol. 1999; 146 609-620
- 50 Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001; 50 2094-2099
- 51 Yang W S, Jeng C Y, Wu T J, Tanaka S, Funahashi T, Matsuzawa Y, Wang J P, Chen C L, Tai T Y, Chuang L M. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care. 2002; 25 376-380
-
52 Warren M P. 1995
Anorexia nervosa. In: Endocrinology. DeGroot LJ (Ed) Philadelphia; W. B. Saunders 2679-2691 - 53 Urwin R E, Bennetts B, Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn K P. Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region. Mol Psychiatry. 2002; 7 652-657
- 54 Delporte M L, Funahashi T, Takahashi M, Matsuzawa Y, Brichard S M. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem J. 2002; 367 677-685
- 55 Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001; 507 142-146
- 56 Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res. 2000; 32 548-554
- 57 Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications. 2003; 301 1045-1050
- 58 Corcos M, Guilbaud O, Paterniti S, Moussa M, Chambry J, Chaouat G, Consoli S M, Jeammet P. Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology. 2003; 28 229-249
- 59 Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 2003; 278 2461-2468
- 60 Yokota T, Meka C S, Medina K L, Igarashi H, Comp P C, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade P W. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest. 2002; 109 1303-1310
- 61 Steppan C M, Lazar M A. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002; 13 18-23
- 62 Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes. Nature. 2001; 409 307-312
- 63 Ghosh S, Singh A K, Aruna B, Mukhopadhyay S, Ehtesham N Z. The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene. 2003; 305 27-34
- 64 Savage D B, Sewter C P, Klenk E S, Segal D G, Vidal-Puig A, Considine R V, O"Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 2001; 50 2199-2202
- 65 Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 2001; 285 561-564
- 66 Fain J N, Cheema P S, Bahouth S W, Lloyd H M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun. 2003; 300 674-678
- 67 Janke J, Engeli S, Gorzelniak K, Luft F C, Sharma A M. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res. 2002; 10 1-5
- 68 McTernan P G, McTernan C L, Chetty R, Jenner K, Fisher F M, Lauer M N, Crocker J, Barnett A H, Kumar S. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab. 2002; 87 2407
- 69 Morash B A, Willkinson D, Ur E, Wilkinson M. Resistin expression and regulation in mouse pituitary. FEBS Lett. 2002; 526 26-30
- 70 Kim K H, Lee K, Moon Y S, Sul H S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001; 276 11 252-11 256
- 71 Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa. J Clin Endocrinol Metab. 1999; 84 1226-1228
- 72 Holden R J, Pakula I S. Tumor necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa?. Med Hypotheses. 1999; 52 155-162
- 73 Raymond N C, Dysken M, Bettin K, Eckert E D, Crow S J, Markus K, Pomeroy C. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int J Eat Disord. 2000; 28 293-302
- 74 Brambilla F, Monti D, Franceschi C. Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa. Psychiatry Res. 2001; 103 107-114
S. M. Brichard
Unité d'Endocrinologie et Métabolisme
UCL 5530 Av. Hippocrate, 55 · 1200 Brussels · Belgium ·
Telefon: +32-2-7645530
Fax: +32-2-7645532
eMail: brichard@endo.ucl.ac.be